Schachner Holly Caren
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
38,976 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Charlene A. Banard
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
60,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
VanDevender Aaron
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
212,659 |
0
|
-
|
|
-
|
Common Stock |
Shawn Cross
|
Director, CEO & Chair of the Board |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
63,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
A. Banard Charlene
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
20,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Mahmood Tahir
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
3,208,307 |
0
|
-
|
|
-
|
Common Stock |
Tahir Mahmood
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
350,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Hants Brandon
|
CFO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
301,225 |
0
|
-
|
|
-
|
Common Stock |
VanDevender Aaron
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
20,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Brandon Hants
|
CFO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
150,672 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Shawn Cross
|
Director, CEO & Chair of the Board |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
94,500 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Shawn Cross
|
Director, CEO & Chair of the Board |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
668,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Caren Holly Schachner
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
20,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
VanDevender Aaron
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
15,395 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Hants Brandon
|
CFO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
20,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Cross Shawn
|
Director, CEO & Chair of the Board |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
300,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
W. Smither John
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
60,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
A. Charlene Banard
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
20,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
John W. Smither
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
20,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Hants Brandon
|
CFO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
57,400 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Cross Shawn
|
Director, CEO & Chair of the Board |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
84,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Holly Caren Schachner
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
20,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
VanDevender Aaron
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
20,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Brandon Hants
|
CFO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
76,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Brandon Hants
|
CFO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
50,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Smither John W.
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
20,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Mahmood Tahir
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
20,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Tahir Mahmood
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
484,738 |
0
|
-
|
|
-
|
Common Stock |
Hants Brandon
|
CFO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
4,328 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Brandon Hants
|
CFO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
35,000 |
0
|
-
|
|
-
|
Stock Option (RIght to Buy) |
Shawn Cross
|
Director, CEO & Chair of the Board |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
545,499 |
0
|
-
|
|
-
|
Common Stock |
Mahmood Tahir
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
164,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Mahmood Tahir
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
27 Dec 2023 |
391,693 |
0
|
-
|
|
-
|
Common Stock |
Brandon Hants
|
CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Dec 2023 |
50,000 |
50,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
John W. Smither
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jun 2023 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Tahir Mahmood
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jun 2023 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Aaron VanDevender
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jun 2023 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Holly Caren Schachner
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jun 2023 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Charlene A. Banard
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jun 2023 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Shawn Cross
|
Director, CEO & Chair of the Board |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Mar 2023 |
668,000 |
668,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Douglas A. Rich
|
Chief Technical Officer |
Sale of securities on an exchange or to another person at price $ 0.50 per share. |
01 Mar 2023 |
482 |
49,316
|
-
|
0.5 |
241
|
Common Stock |
Tahir Mahmood
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 0.50 per share. |
01 Mar 2023 |
1,802 |
73,626
|
-
|
0.5 |
901
|
Common Stock |
Shawn Cross
|
President & COO |
Sale of securities on an exchange or to another person at price $ 0.50 per share. |
01 Mar 2023 |
934 |
60,156
|
-
|
0.5 |
467
|
Common Stock |
Bittoo Kanwar
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 0.50 per share. |
01 Mar 2023 |
539 |
78,005
|
-
|
0.5 |
270
|
Common Stock |
Brandon Hants
|
CFO |
Sale of securities on an exchange or to another person at price $ 0.50 per share. |
01 Mar 2023 |
504 |
32,315
|
-
|
0.5 |
252
|
Common Stock |
Douglas A. Rich
|
Chief Technical Officer |
Sale of securities on an exchange or to another person at price $ 1.05 per share. |
02 Dec 2022 |
4,229 |
49,798
|
-
|
1.1 |
4,441
|
Common Stock |
Tahir Mahmood
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
02 Dec 2022 |
1,772 |
75,428
|
-
|
|
0
|
Common Stock |
Randall Mrsny
|
Director |
Sale of securities on an exchange or to another person at price $ 1.05 per share. |
02 Dec 2022 |
418 |
21,136
|
-
|
1.1 |
439
|
Common Stock |
Shawn Cross
|
President & COO |
Sale of securities on an exchange or to another person at price $ 1.05 per share. |
02 Dec 2022 |
3,893 |
61,090
|
-
|
1.1 |
4,088
|
Common Stock |
Bittoo Kanwar
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 1.05 per share. |
02 Dec 2022 |
3,488 |
78,544
|
-
|
1.1 |
3,663
|
Common Stock |
Brandon Hants
|
CFO |
Sale of securities on an exchange or to another person at price $ 1.05 per share. |
02 Dec 2022 |
1,959 |
32,819
|
-
|
1.1 |
2,057
|
Common Stock |
Aaron VanDevender
|
Director |
Purchase of securities on an exchange or from another person at price $ 1.00 per share. |
25 Nov 2022 |
50,000 |
212,659
|
-
|
1.0 |
49,975
|
Common Stock |
Aaron VanDevender
|
Director |
Purchase of securities on an exchange or from another person at price $ 1.00 per share. |
25 Nov 2022 |
100,000 |
162,659
|
-
|
1.0 |
99,660
|
Common Stock |
Douglas A. Rich
|
Chief Technical Officer |
Sale of securities on an exchange or to another person at price $ 1.42 per share. |
01 Sep 2022 |
448 |
54,027
|
-
|
1.4 |
636
|
Common Stock |
Tahir Mahmood
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 1.42 per share. |
01 Sep 2022 |
1,723 |
74,154
|
-
|
1.4 |
2,447
|
Common Stock |
Randall Mrsny
|
Director |
Sale of securities on an exchange or to another person at price $ 1.42 per share. |
01 Sep 2022 |
404 |
21,554
|
-
|
1.4 |
574
|
Common Stock |
Shawn Cross
|
President & COO |
Sale of securities on an exchange or to another person at price $ 1.42 per share. |
01 Sep 2022 |
416 |
64,983
|
-
|
1.4 |
591
|
Common Stock |
Shawn Cross
|
President & COO |
Sale of securities on an exchange or to another person at price $ 1.42 per share. |
01 Sep 2022 |
468 |
65,399
|
-
|
1.4 |
665
|
Common Stock |
Bittoo Kanwar
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 1.42 per share. |
01 Sep 2022 |
503 |
82,028
|
-
|
1.4 |
714
|
Common Stock |
Brandon Hants
|
CFO |
Sale of securities on an exchange or to another person at price $ 1.42 per share. |
01 Sep 2022 |
462 |
34,774
|
-
|
1.4 |
656
|
Common Stock |
Shawn Cross
|
President & COO |
Sale of securities on an exchange or to another person at price $ 3.04 per share. |
01 Jun 2022 |
2,166 |
65,867
|
-
|
3.0 |
6,590
|
Common Stock |
Shawn Cross
|
President & COO |
Sale of securities on an exchange or to another person at price $ 2.97 per share. |
01 Jun 2022 |
1,767 |
67,983
|
-
|
3.0 |
5,244
|
Common Stock |
Bittoo Kanwar
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 2.97 per share. |
01 Jun 2022 |
1,792 |
82,808
|
-
|
3.0 |
5,318
|
Common Stock |
Bittoo Kanwar
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 3.04 per share. |
01 Jun 2022 |
2,196 |
80,612
|
-
|
3.0 |
6,681
|
Common Stock |
Brandon Hants
|
CFO |
Sale of securities on an exchange or to another person at price $ 3.04 per share. |
01 Jun 2022 |
1,122 |
33,263
|
-
|
3.0 |
3,414
|
Common Stock |
Brandon Hants
|
CFO |
Sale of securities on an exchange or to another person at price $ 2.97 per share. |
01 Jun 2022 |
915 |
34,385
|
-
|
3.0 |
2,716
|
Common Stock |
John W. Smither
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2022 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
David A. Lamond
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2022 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Randall Mrsny
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2022 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Aaron VanDevender
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2022 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Holly Caren Schachner
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2022 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Charlene A. Banard
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2022 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
David A. Lamond
|
Director |
Purchase of securities on an exchange or from another person at price $ 3.08 per share. |
20 May 2022 |
33,000 |
1,044,019
|
-
|
3.1 |
101,640
|
Common Stock |
David A. Lamond
|
Director |
Purchase of securities on an exchange or from another person at price $ 3.26 per share. |
20 May 2022 |
33,500 |
1,077,519
|
-
|
3.3 |
109,210
|
Common Stock |
Shawn Cross
|
President & COO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 May 2022 |
18,000 |
69,750
|
-
|
|
0
|
Common Stock |
Shawn Cross
|
President & COO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 May 2022 |
84,000 |
84,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Brandon Hants
|
CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 May 2022 |
35,000 |
35,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Brandon Hants
|
CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 May 2022 |
7,500 |
35,300
|
-
|
|
0
|
Common Stock |
Charlene A. Banard
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2022 |
60,000 |
60,000
|
-
|
|
-
|
Right to Buy (Stock Option) |
Aaron VanDevender
|
Director |
Purchase of securities on an exchange or from another person at price $ 6.34 per share. |
28 Feb 2022 |
45,888 |
62,659
|
-
|
6.3 |
290,930
|
Common Stock |
Aaron VanDevender
|
Director |
Purchase of securities on an exchange or from another person at price $ 6.51 per share. |
28 Feb 2022 |
4,112 |
16,771
|
-
|
6.5 |
26,769
|
Common Stock |
Douglas A. Rich
|
Chief Technical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2022 |
89,600 |
89,600
|
-
|
|
-
|
Stock Option (Right to Buy) |
Douglas A. Rich
|
Chief Technical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2022 |
19,200 |
59,200
|
-
|
|
0
|
Common Stock |
Elizabeth Bhatt
|
Chief Bus. & Strategy Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2022 |
17,250 |
48,750
|
-
|
|
0
|
Common Stock |
Elizabeth Bhatt
|
Chief Bus. & Strategy Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2022 |
80,500 |
80,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
Tahir Mahmood
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2022 |
350,000 |
350,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Tahir Mahmood
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2022 |
75,000 |
78,000
|
-
|
|
0
|
Common Stock |
Randall Mrsny
|
Director, Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2022 |
17,250 |
20,750
|
-
|
|
0
|
Common Stock |
Randall Mrsny
|
Director, Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2022 |
80,500 |
80,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
Shawn Cross
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2022 |
94,500 |
94,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
Shawn Cross
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2022 |
20,250 |
51,750
|
-
|
|
0
|
Common Stock |
Bittoo Kanwar
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2022 |
21,600 |
84,600
|
-
|
|
0
|
Common Stock |
Bittoo Kanwar
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2022 |
100,800 |
100,800
|
-
|
|
-
|
Stock Option (Right to Buy) |
Brandon Hants
|
VP, Finance & Bus. Ops. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2022 |
57,400 |
57,400
|
-
|
|
-
|
Stock Option (Right to Buy) |
Brandon Hants
|
VP, Finance & Bus. Ops. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2022 |
12,300 |
27,800
|
-
|
|
0
|
Common Stock |
Tahir Mahmood
|
Director, Chief Executive Officer |
Purchase of securities on an exchange or from another person at price $ 7.88 per share. |
28 Jan 2022 |
3,000 |
3,000
|
-
|
7.9 |
23,640
|
Common Stock |
Graham K. Cooper
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2022 |
300,000 |
300,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
John W. Smither
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2022 |
60,000 |
60,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Bittoo Kanwar
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
22 Dec 2021 |
31,500 |
104,172
|
-
|
|
-
|
Stock Option (Right to Buy) |
Bittoo Kanwar
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.38 per share. |
22 Dec 2021 |
31,500 |
31,500
|
-
|
2.4 |
74,970
|
Common Stock |
Randall Mrsny
|
Director, Chief Scientific Officer |
Purchase of securities on an exchange or from another person at price $ 14.99 per share. |
09 Dec 2021 |
3,500 |
3,500
|
-
|
15.0 |
52,464
|
Common Stock |
Helen S. Kim
|
Director |
Sale of securities on an exchange or to another person at price $ 30.03 per share. |
24 Aug 2021 |
505 |
599,495
|
-
|
30.0 |
15,165
|
Common Stock |
Helen S. Kim
|
Director |
Sale of securities on an exchange or to another person at price $ 30.08 per share. |
24 Aug 2021 |
9,478 |
590,014
|
-
|
30.1 |
285,075
|
Common Stock |
Helen S. Kim
|
Director |
Sale of securities on an exchange or to another person at price $ 30.00 per share. |
24 Aug 2021 |
3 |
599,492
|
-
|
30 |
90
|
Common Stock |
Holly Caren Schachner
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Aug 2021 |
38,976 |
38,976
|
-
|
|
-
|
Stock Option (Right to Buy) |
Shawn Cross
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 30.01 per share. |
19 Aug 2021 |
300 |
0
|
-
|
30.0 |
9,003
|
Common Stock |
Shawn Cross
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
19 Aug 2021 |
9,700 |
300,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Shawn Cross
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
19 Aug 2021 |
300 |
309,700
|
-
|
|
-
|
Stock Option (Right to Buy) |
Shawn Cross
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 30.12 per share. |
19 Aug 2021 |
9,700 |
0
|
-
|
30.1 |
292,190
|
Common Stock |
Shawn Cross
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.61 per share. |
19 Aug 2021 |
9,700 |
9,700
|
-
|
4.6 |
44,717
|
Common Stock |
Shawn Cross
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.61 per share. |
19 Aug 2021 |
300 |
300
|
-
|
4.6 |
1,383
|
Common Stock |
Elizabeth Bhatt
|
Chief Bus. & Strategy Officer |
Sale of securities on an exchange or to another person at price $ 36.41 per share. |
21 Jul 2021 |
6,640 |
2,360
|
-
|
36.4 |
241,762
|
Common Stock |
Elizabeth Bhatt
|
Chief Bus. & Strategy Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 Jul 2021 |
9,000 |
292,632
|
-
|
|
-
|
Stock Option (Right to Buy) |
Elizabeth Bhatt
|
Chief Bus. & Strategy Officer |
Sale of securities on an exchange or to another person at price $ 37.43 per share. |
21 Jul 2021 |
2,360 |
0
|
-
|
37.4 |
88,335
|
Common Stock |
Elizabeth Bhatt
|
Chief Bus. & Strategy Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.61 per share. |
21 Jul 2021 |
9,000 |
9,000
|
-
|
4.6 |
41,490
|
Common Stock |
Bittoo Kanwar
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 42.01 per share. |
07 Jul 2021 |
6,651 |
849
|
-
|
42.0 |
279,409
|
Common Stock |
Bittoo Kanwar
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
07 Jul 2021 |
7,500 |
135,672
|
-
|
|
-
|
Stock Option (Right to Buy) |
Bittoo Kanwar
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 43.84 per share. |
07 Jul 2021 |
49 |
0
|
-
|
43.8 |
2,148
|
Common Stock |
Bittoo Kanwar
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 42.67 per share. |
07 Jul 2021 |
800 |
49
|
-
|
42.7 |
34,136
|
Common Stock |
Bittoo Kanwar
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.38 per share. |
07 Jul 2021 |
7,500 |
7,500
|
-
|
2.4 |
17,850
|
Common Stock |
Helen S. Kim
|
Director |
Sale of securities on an exchange or to another person at price $ 43.30 per share. |
02 Jul 2021 |
198,759 |
601,241
|
-
|
43.3 |
8,606,265
|
Common Stock |
Helen S. Kim
|
Director |
Sale of securities on an exchange or to another person at price $ 46.31 per share. |
02 Jul 2021 |
1,241 |
600,000
|
-
|
46.3 |
57,466
|
Common Stock |
Graham K. Cooper
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 May 2021 |
15,107 |
15,107
|
-
|
|
-
|
Stock Option (Right to Buy) |
Helen S. Kim
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 May 2021 |
14,343 |
14,343
|
-
|
|
-
|
Stock Option (Right to Buy) |
David A. Lamond
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 May 2021 |
15,175 |
15,175
|
-
|
|
-
|
Stock Option (Right to Buy) |
Aaron VanDevender
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 May 2021 |
15,395 |
15,395
|
-
|
|
-
|
Stock Option (Right to Buy) |
Elizabeth Bhatt
|
Chief Bus. & Strategy Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.61 per share. |
21 Apr 2021 |
9,000 |
9,000
|
-
|
4.6 |
41,490
|
Common Stock |
Elizabeth Bhatt
|
Chief Bus. & Strategy Officer |
Sale of securities on an exchange or to another person at price $ 39.30 per share. |
21 Apr 2021 |
971 |
8,029
|
-
|
39.3 |
38,160
|
Common Stock |
Elizabeth Bhatt
|
Chief Bus. & Strategy Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 Apr 2021 |
9,000 |
301,632
|
-
|
|
-
|
Stock Option (Right to Buy) |
Elizabeth Bhatt
|
Chief Bus. & Strategy Officer |
Sale of securities on an exchange or to another person at price $ 41.21 per share. |
21 Apr 2021 |
2,612 |
0
|
-
|
41.2 |
107,649
|
Common Stock |
Elizabeth Bhatt
|
Chief Bus. & Strategy Officer |
Sale of securities on an exchange or to another person at price $ 40.38 per share. |
21 Apr 2021 |
5,417 |
2,612
|
-
|
40.4 |
218,749
|
Common Stock |
Bittoo Kanwar
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 53.48 per share. |
07 Apr 2021 |
2,251 |
5,249
|
-
|
53.5 |
120,383
|
Common Stock |
Bittoo Kanwar
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
07 Apr 2021 |
7,500 |
143,172
|
-
|
|
-
|
Stock Option (Right to Buy) |
Bittoo Kanwar
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 56.59 per share. |
07 Apr 2021 |
1,188 |
0
|
-
|
56.6 |
67,229
|
Common Stock |
Bittoo Kanwar
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 55.51 per share. |
07 Apr 2021 |
1,926 |
1,188
|
-
|
55.5 |
106,912
|
Common Stock |
Bittoo Kanwar
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 54.53 per share. |
07 Apr 2021 |
2,135 |
3,114
|
-
|
54.5 |
116,422
|
Common Stock |
Bittoo Kanwar
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.38 per share. |
07 Apr 2021 |
7,500 |
7,500
|
-
|
2.4 |
17,850
|
Common Stock |
David A. Lamond
|
Director |
Purchase of securities on an exchange or from another person at price $ 42.00 per share. |
06 Apr 2021 |
25,000 |
1,011,019
|
-
|
42 |
1,050,000
|
Common Stock |
Elizabeth Bhatt
|
Chief Bus. & Strategy Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2021 |
63,000 |
63,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Tahir Mahmood
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2021 |
164,000 |
164,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Randall Mrsny
|
Director, Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2021 |
164,000 |
164,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Shawn Cross
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2021 |
63,000 |
63,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Bittoo Kanwar
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2021 |
63,000 |
63,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Brandon Hants
|
VP, Finance & Bus. Ops. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2021 |
76,000 |
76,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Douglas A. Rich
|
Chief Technical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Feb 2021 |
80,000 |
80,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
David A. Lamond
|
None |
|
09 Jun 2020 |
1 |
0
|
-
|
|
-
|
Series B Preferred Stock |
David A. Lamond
|
None |
|
09 Jun 2020 |
1 |
0
|
-
|
|
-
|
Series A Preferred Stock |
David A. Lamond
|
None |
Grant, award, or other acquisition of securities at price $ 14.00 per share. |
09 Jun 2020 |
71,430 |
986,019
|
-
|
14 |
1,000,020
|
Common Stock |
David A. Lamond
|
None |
|
09 Jun 2020 |
1 |
0
|
-
|
|
-
|
Series C Preferred Stock |
David A. Lamond
|
None |
|
09 Jun 2020 |
914,589 |
914,589
|
-
|
|
-
|
Common Stock |
Aaron VanDevender
|
None |
|
09 Jun 2020 |
7,814 |
0
|
-
|
|
-
|
Series A Preferred Stock |
Aaron VanDevender
|
None |
|
09 Jun 2020 |
2,296 |
0
|
-
|
|
-
|
Series C Preferred Stock |
Aaron VanDevender
|
None |
|
09 Jun 2020 |
2,549 |
0
|
-
|
|
-
|
Series B Preferred Stock |
Aaron VanDevender
|
None |
|
09 Jun 2020 |
12,659 |
12,659
|
-
|
|
-
|
Common Stock |
Bittoo Kanwar
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2020 |
60,942 |
60,942
|
-
|
|
-
|
Stock Option (Right to Buy) |
Brandon Hants
|
VP, Finance & Bus. Ops. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2020 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (Right to Buy) |